Reactivity of 5-HT1A receptor in adult rats after neonatal noradrenergic neurons' lesion - Implications for antidepressant-like action

Brain Research

Volumn 1239, Issue , 2008, Pages 66-76

  Dabrowska, Joanna ^a   Nowak, Przemyslaw ^a   Brus, Ryszard ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

5 HT1A; DSP 4; Noradrenaline; R (+) 8 OH DPAT; Serotonin; WAY 100635

Indexed keywords

2 BROMO N (2 CHLOROETHYL) N ETHYLBENZYLAMINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; AUTORECEPTOR; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 1A RECEPTOR; ZIMELDINE; ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIDEPRESSANT AGENT; BENZYLAMINE DERIVATIVE; NORADRENALIN; SEROTONIN; SEROTONIN AGONIST; SEROTONIN UPTAKE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FORCED SWIMMING TEST; IMMOBILIZATION; LEARNED HELPLESSNESS; MALE; MICRODIALYSIS; NERVE CELL LESION; NEWBORN; NONHUMAN; NORADRENERGIC NERVE; NORADRENERGIC SYSTEM; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; SEROTONIN RELEASE; ANIMAL; DEPRESSION; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; NERVE CELL; TIME; WISTAR RAT;

ANIMALIA; RATTUS;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ADRENERGIC AGENTS; ANIMALS; ANIMALS, NEWBORN; ANTIDEPRESSIVE AGENTS; BENZYLAMINES; DEPRESSION; HELPLESSNESS, LEARNED; MALE; NEURONS; NOREPINEPHRINE; PREFRONTAL CORTEX; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS; ZIMELDINE;

EID: 53949114437     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.08.054     Document Type: Article

References (86)

1. Adell A., and Artigas F. A microdialysis study of the in vivo release of 5-HT in the median raphe nucleus of the rat. Br. J. Pharmacol. 125 (1998) 1361-1367
2. Adell A., and Artigas F. Regulation of the release of 5-hydroxytryptamine in the median raphe nucleus of the rat by catecholaminergic afferents. Eur. J. Neurosci. 11 (1999) 2305-2311
3. Amargos-Bosch M., Adell A., Bortolozzi A., and Artigas F. Stimulation of alpha1-adrenoceptors in the rat medial prefrontal cortex increases the local in vivo 5-hydroxytryptamine release: reversal by antipsychotic drugs. J. Neurochem. 87 (2003) 831-842
4. Archer T., Arwestrom E., Minor B.G., Persson M.L., Post C., Sundstrom E., and Jonsson G. (+)-8-OH-DPAT and 5-MeODMT induced analgesia is antagonised by noradrenaline depletion. Physiol. Behav. 39 (1987) 95-102
5. Arvidsson L.E., Hacksell U., Nilsson J.L., Hjorth S., Carlsson A., Lindberg P., Sanchez D., and Wikstrom H. 8-Hydroxy-2-(di-N-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist. J. Med. Chem. 24 (1981) 921-923
6. Barnes N.M., and Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 38 (1999) 1083-1152
7. Blier P., and Ward N.M. Is there a role for 5-HT1A agonists in the treatment of depression?. Biol. Psychiatry 53 (2003) 193-203
8. Blier P., Pineyro G., el Mansari M., Bergeron R., and de Montigny C. Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission. Ann. N. Y. Acad. Sci. 861 (1998) 204-216
9. Bortolozzi A., and Artigas F. Control of 5-hydroxytryptamine release in the dorsal raphe nucleus by the noradrenergic system in rat brain. Role of alpha-adrenoceptors. Neuropsychopharmacology 28 (2003) 421-434
10. Celada P., Puig M.V., Casanovas J.M., Guillazo G., and Artigas F. Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: Involvement of serotonin-1A, GABA(A), and glutamate receptors. J. Neurosci. 21 (2001) 9917-9929
11. Celada P., Puig M., Amargos-Bosch M., Adell A., and Artigas F. The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. J. Psychiatry Neurosci. 29 (2004) 252-265
12. Cryan J.F., Page M.E., and Lucki I. Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test. Eur. J. Pharmacol. 436 (2002) 197-205
13. Dabrowska J., Nowak P., and Brus R. Desensitization of 5-HT(1A) autoreceptors induced by neonatal DSP-4 treatment. Eur. Neuropsychopharmacol. 17 2 (2007) 129-137 Jan 15
14. Danysz W., Kostowski W., Kozak W., and Hauptmann M. On the role of noradrenergic neurotransmission in the action of desipramine and amitriptyline in animal models of depression. Pol. J. Pharmacol. Pharm. 38 (1986) 285-298
15. Day H.E., Campeau S., Watson Jr. S.J., and Akil H. Distribution of alpha 1a-, alpha 1b- and alpha 1d-adrenergic receptor mRNA in the rat brain and spinal cord. J. Chem. Neuroanat. 13 (1997) 115-139
16. Dooley D.J., Bittiger H., Hauser K.L., Bischoff S.F., and Waldmeier P.C. Alteration of central alpha 2- and beta-adrenergic receptors in the rat after DSP-4, a selective noradrenergic neurotoxin. Neuroscience 9 (1983) 889-898
17. Dooley D.J., Mogilnicka E., Delini-Stula A., Waechter F., Truog A., and Wood J. Functional supersensitivity to adrenergic agonists in the rat after DSP-4, a selective noradrenergic neurotoxin. Psychopharmacology (Berl) 81 (1983) 1-5
18. Ebenezer I.S. Effects of the 5HT1A agonist, 8-OH-DPAT, on operant food intake in non-deprived rats. Neuroreport 3 (1992) 62-64
19. Eison A.S., and Eison M.S. Serotonergic mechanisms in anxiety. Prog. Neuropsychopharmacol. Biol. Psychiatry 18 (1994) 47-62
20. Fernandez-Guasti A., and Rodriguez-Manzo G. 8-OH-DPAT and male rat sexual behavior: partial blockade by noradrenergic lesion and sexual exhaustion. Pharmacol. Biochem. Behav. 56 (1997) 111-116
21. 1A receptor modulation of anxiety in two ethological animal tests. J. Neurosci. 16 (1996) 4810-4815
22. Haddjeri N., Blier P., and de Montigny C. Effect of the alpha-2 adrenoceptor antagonist mirtazapine on the 5-hydroxytryptamine system in the rat brain. J. Pharmacol. Exp. Ther. 277 (1996) 861-871
23. Hadrava V., Blier P., and de Montigny C. Partial agonistic activity of R- and S-enantiomers of 8-OH-DPAT at 5-HT1A receptors. J. Psychiatry Neurosci. 21 (1996) 101-108
24. Haidkind R., Eller M., Harro M., Kask A., Rinken A., Oreland L., and Harro J. Effects of partial locus coeruleus denervation and chronic mild stress on behaviour and monoamine neurochemistry in the rat. Eur. Neuropsychopharmacol. 13 (2003) 19-28
25. Harro J., and Oreland L. Depression as a spreading adjustment disorder of monoaminergic neurons: a case for primary implication of the locus coeruleus. Brain Res. Brain Res. Rev. 38 (2001) 79-128
26. Harro J., Oreland L., Vasar E., and Bradwejn J. Impaired exploratory behaviour after DSP-4 treatment in rats: implications for the increased anxiety after noradrenergic denervation. Eur. Neuropsychopharmacol. 5 (1995) 447-455
27. Harro J., Haidkind R., Harro M., Modiri A.R., Gillberg P.G., Pahkla R., Matto V., and Oreland L. Chronic mild unpredictable stress after noradrenergic denervation: attenuation of behavioural and biochemical effects of DSP-4 treatment. Eur. Neuropsychopharmacol. 10 (1999) 5-16
28. Harro J., Pahkla R., Modiri A.R., Harro M., Kask A., and Oreland L. Dose-dependent effects of noradrenergic denervation by DSP-4 treatment on forced swimming and beta-adrenoceptor binding in the rat. J. Neural. Transm. 106 (1999) 619-629
29. Heal D.J., Butler S.A., Prow M.R., and Buckett W.R. Quantification of presynaptic alpha 2-adrenoceptors in rat brain after short-term DSP-4 lesioning. Eur. J. Pharmacol. 249 (1993) 37-41
30. Hopwood S.E., and Stamford J.A. Noradrenergic modulation of serotonin release in rat dorsal and median raphe nuclei via alpha(1) and alpha(2A) adrenoceptors. Neuropharmacology 41 (2001) 433-442
31. Jaim-Etcheverry G. 2-Chloroethylamines (DSP-4 and xylamines): toxic actions on noradrenergic neurons. In: Kostrzewa R.M. (Ed). Highly Selective Neurotoxins: Basic and Clinical Applications Vol. (1998), Humana Press Inc., Totowa, New Jersey 131-140
32. Joca S.R., Padovan C.M., and Guimaraes F.S. Activation of post-synaptic 5-HT(1A) receptors in the dorsal hippocampus prevents learned helplessness development. Brain Res. 978 (2003) 177-184
33. Jolas T., Schreiber R., Laporte A.M., Chastanet M., De Vry J., Glaser T., Adrien J., and Hamon M. Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat?. J. Pharmacol. Exp. Ther. 272 (1995) 920-929
34. Jonsson G., and Hallman H. Response of central monoamine neurons following an early neurotoxic lesion. Bibl. Anat. (1982) 76-92
35. Jonsson G., Hallman H., Ponzio F., and Ross S. DSP-4 (N-(2-chlorethyl)-N-ethyl-2-bromo-benzylamine) - a useful denervation tool for central and peripheral noradrenaline neurons. Eur. J. Pharmacol. 72 (1981) 178-188
36. Jonsson G., Hallman H., and Sundstrom E. Effects of the noradrenaline neurotoxin DSP4 on the postnatal development of central noradrenaline neurons in the rat. Neuroscience 7 (1982) 2895-2907
37. Kennett G.A., Marcou M., Dourish C.T., and Curzon G. Single administration of 5-HT1A agonists decreases 5-HT1A presynaptic, but not postsynaptic receptor-mediated responses: relationship to antidepressant-like action. Eur. J. Pharmacol. 138 (1987) 53-60
38. Klimek V., Stockmeier C., Overholser J., Meltzer H.Y., Kalka S., Dilley G., and Ordway G.A. Reduced levels of norepinephrine transporters in the locus coeruleus in major depression. J. Neurosci. 17 (1997) 8451-8458
39. Konig J.F.R., and Klippel R.A. The rat brain. A Stereotaxic Atlas of the Forebrain and Lower Parts of the Brain Stem Vol. (1963), The Williams & Wilkins Company, Baltimore
40. Laporte A.M., Fattaccini C.M., Lombard M.C., Chauveau J., and Hamon M. Effects of dorsal rhizotomy and selective lesion of serotonergic and noradrenergic systems on 5-HT1A, 5-HT1B, and 5-HT3 receptors in the rat spinal cord. J. Neural. Transm. Gen. Sect. 100 (1995) 207-223
41. Le Poul E., Boni C., Hanoun N., Laporte A.M., Laaris N., Chauveau J., Hamon M., and Lanfumey L. Differential adaptation of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine. Neuropharmacology 39 (2000) 110-122
42. Lin M.T., Tsay H.J., Su W.H., and Chueh F.Y. Changes in extracellular serotonin in rat hypothalamus affect thermoregulatory function. Am. J. Physiol. 274 (1998) R1260-1267
43. Lucki I., Singh A., and Kreiss D.S. Antidepressant-like behavioral effects of serotonin receptor agonists. Neurosci. Biobehav. Rev. 18 (1994) 85-95
44. 1A receptors. Br. J. Pharmacol. 108 (1993) 669-677
45. Martin P., Beninger R.J., Hamon M., and Puech A.J. Antidepressant-like action of 8-OH-DPAT, a 5-HT1A agonist, in the learned helplessness paradigm: evidence for a postsynaptic mechanism. Behav. Brain Res. 38 (1990) 135-144
46. Matsuda T., Somboonthum P., Suzuki M., Asano S., and Baba A. Antidepressant-like effect by postsynaptic 5-HT1A receptor activation in mice. Eur. J. Pharmacol. 280 (1995) 235-238
47. McQuade R., and Sharp T. Functional mapping of dorsal and median raphe 5-hydroxytryptamine pathways in forebrain of the rat using microdialysis. J. Neurochem. 69 (1997) 791-796
48. Mongeau R., Blier P., and de Montigny C. The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments. Brain Res. Brain Res. Rev. 23 (1997) 145-195
49. Nowak P., Bortel A., Dabrowska J., Labus Ł., Brus R., and Kostrzewa R.M. Effect of neonatal DSP-4 administration on biogenic amine levels and amphetamine-induced release into microdialysates of adult rat frontal cortex. Pol. J. Pharmacol. 56 Suppl. (2004) 248-249
50. Nowak P., Dabrowska J., Bortel A., Biedka I., Szczerbak G., Slomian G., Kostrzewa R.M., and Brus R. Histamine H3 receptor agonist- and antagonist-evoked vacuous chewing movements in 6-OHDA-lesioned rats occurs in an absence of change in microdialysate dopamine levels. Eur. J. Pharmacol. 552 (2006) 46-54
51. Nowak P., Bortel A., Dabrowska J., Oswiecimska J., Drosik M., Kwiecinski A., Opara J., Kostrzewa R.M., and Brus R. Amphetamine and mCPP effects on dopamine and serotonin striatal in vivo microdialysates in an animal model of hyperactivity. Neurotox. Res. 11 (2007) 131-144
52. O'Connell M.T., and Curzon G. A comparison of the effects of 8-OH-DPAT pretreatment of different behavioural responses to 8-OH-DPAT. Eur. J. Pharmacol. 312 (1996) 137-143
53. O'Connell M.T., Sarna G.S., and Curzon G. Evidence for postsynaptic mediation of the hypothermic effect of 5-HT1A receptor activation. Br. J. Pharmacol. 106 (1992) 603-609
54. O'Leary O.F., Bechtholt A.J., Crowley J.J., Valentino R.J., and Lucki I. The role of noradrenergic tone in the dorsal raphe nucleus of the mouse in the acute behavioral effects of antidepressant drugs. Eur. Neuropsychopharmacol. 17 (2007) 215-226
55. O'Neill M.F., and Conway M.W. Role of 5-HT(1A) and 5-HT(1B) receptors in the mediation of behavior in the forced swim test in mice. Neuropsychopharmacology 24 (2001) 391-398
56. Ordway G.A., Stockmeier C.A., Cason G.W., and Klimek V. Pharmacology and distribution of norepinephrine transporters in the human locus coeruleus and raphe nuclei. J. Neurosci. 17 (1997) 1710-1719
57. Parks C.L., Robinson P.S., Sibille E., Shenk T., and Toth M. Increased anxiety of mice lacking the serotonin1A receptor. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 10734-10739
58. Petty F., Kramer G., Wilson L., and Jordan S. In vivo serotonin release and learned helplessness. Psychiatry Res. 52 (1994) 285-293
59. Pineyro G., and Blier P. Autoregulation of serotonin neurons: role in antidepressant drug action. Pharmacol. Rev. 51 (1999) 533-591
60. Porsolt R.D., Anton G., Blavet N., and Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur. J. Pharmacol. 47 (1978) 379-391
61. Prow M.R., Martin K.F., and Heal D.J. 8-OH-DPAT-induced mydriasis in mice: a pharmacological characterisation. Eur. J. Pharmacol. 317 (1996) 21-28
62. Przegaliński E., Moryl E., and Papp M. The effect of 5-HT1A receptor ligands in a chronic mild stress model of depression. Neuropharmacology 34 (1995) 1305-1310
63. Pudovkina O.L., Cremers T.I., and Westerink B.H. The interaction between the locus coeruleus and dorsal raphe nucleus studied with dual-probe microdialysis. Eur. J. Pharmacol. 445 (2002) 37-42
64. Pudovkina O.L., Cremers T.I., and Westerink B.H. Regulation of the release of serotonin in the dorsal raphe nucleus by alpha1 and alpha2 adrenoceptors. Synapse 50 (2003) 77-82
65. Puig M.V., Artigas F., and Celada P. Modulation of the activity of pyramidal neurons in rat prefrontal cortex by raphe stimulation in vivo: involvement of serotonin and GABA. Cereb. Cortex. 15 (2005) 1-14
66. Redrobe J.P., and Bourin M. Clonidine potentiates the effects of 5-HT1A, 5-HT1B and 5-HT2A/2C antagonists and 8-OH-DPAT in the mouse forced swimming test. Eur. Neuropsychopharmacol. 8 (1998) 169-173
67. Riad M., Watkins K.C., Doucet E., Hamon M., and Descarries L. Agonist-induced internalization of serotonin-1a receptors in the dorsal raphe nucleus (autoreceptors) but not hippocampus (heteroreceptors). J. Neurosci. 21 (2001) 8378-8386
68. Ross S.B. Long-term effects of N-2-chlorethyl-N-ethyl-2-bromobenzylamine hydrochloride on noradrenergic neurones in the rat brain and heart. Br. J. Pharmacol. 58 (1976) 521-527
69. Scheinin M., Lomasney J.W., Hayden-Hixson D.M., Schambra U.B., Caron M.G., Lefkowitz R.J., and Fremeau Jr. R.T. Distribution of alpha 2-adrenergic receptor subtype gene expression in rat brain. Brain Res. Mol. Brain Res. 21 (1994) 133-149
70. Seligman M.E., and Beagley G. Learned helplessness in the rat. J. Comp. Physiol. Psychol. 88 (1975) 534-541
71. Semba J.I., and Takahashi R. Effect of monoamine precursors on the forced-swimming test in mice. Psychopharmacology (Berl) 95 (1988) 222-225
72. Shirayama Y., Chen A.C., Nakagawa S., Russell D.S., and Duman R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J. Neurosci. 22 (2002) 3251-3261
73. Simansky K.J. Serotonergic control of the organization of feeding and satiety. Behav. Brain Res. 73 (1996) 37-42
74. Steciuk M., Kram M., Kramer G.L., and Petty F. Decrease in stress-induced c-Fos-like immunoreactivity in the lateral septal nucleus of learned helpless rats. Brain Res. 822 (1999) 256-259
75. Stockmeier C.A., Shapiro L.A., Dilley G.E., Kolli T.N., Friedman L., and Rajkowska G. Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. J. Neurosci. 18 (1998) 7394-7401
76. Svensson T.H., Bunney B.S., and Aghajanian G.K. Inhibition of both noradrenergic and serotonergic neurons in brain by the alpha-adrenergic agonist clonidine. Brain Res. 92 (1975) 291-306
77. Takeda H., Matsumiya T., and Shibuya T. Detection and identification modes for the highly sensitive and simultaneous determination of various biogenic amines by coulometric high-performance liquid chromatography. J. Chromatogr. 515 (1990) 265-278
78. Talley E.M., Rosin D.L., Lee A., Guyenet P.G., and Lynch K.R. Distribution of alpha 2A-adrenergic receptor-like immunoreactivity in the rat central nervous system. J. Comp. Neurol. 372 (1996) 111-134
79. Toth M. 5-HT1A receptor knockout mouse as a genetic model of anxiety. Eur. J. Pharmacol. 463 (2003) 177-184
80. Valentino R.J., Curtis A.L., Parris D.G., and Wehby R.G. Antidepressant actions on brain noradrenergic neurons. J. Pharmacol. Exp. Ther. 253 (1990) 833-840
81. Vandermaelen C.P., and Aghajanian G.K. Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices. Brain Res. 289 (1983) 109-119
82. Vetulani J., and Sulser F. Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain. Nature 257 (1975) 495-496
83. 1A agonists measured with the forced swim test. Psychopharmacology (Berl) 101 (1990) 497-504
84. Wu J., Kramer G.L., Kram M., Steciuk M., Crawford I.L., and Petty F. Serotonin and learned helplessness: a regional study of 5-HT1A, 5-HT2A receptors and the serotonin transport site in rat brain. J. Psychiatr. Res. 33 (1999) 17-22
85. Yasuda R.P., Dunwiddie T.V., and Zahniser N.R. The acute effects of 6-hydroxydopamine treatment on noradrenergic function in the rat hippocampus in vitro. Brain Res. 367 (1986) 121-127
86. Yoshioka M., Matsumoto M., Togashi H., Smith C.B., and Saito H. Alpha 2-adrenoceptor modulation of 5-HT biosynthesis in the rat brain. Neurosci. Lett. 139 (1992) 53-56